Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Primary antibodies

Anti-Toxoplasma gondii SAG1/Major surface antigen p30 Antibody (SAA2154) (JN902013)

Anti-Toxoplasma gondii SAG1/Major surface antigen p30 Antibody (SAA2154)
Anti-Toxoplasma gondii SAG1/Major surface antigen p30 Antibody (SAA2154)
Anti-Toxoplasma gondii SAG1/Major surface antigen p30 Antibody (SAA2154)
Anti-Toxoplasma gondii SAG1/Major surface antigen p30 Antibody (SAA2154)
  • icon
Price(USD): $
Spec:
  • 20ug
  • 50ug
  • 100ug
  • 1mg
Number:
Contact us
  • Overview

  • Images

  • References

  • Datasheet

Overview
Catalog No.JN902013
Description
Anti-Toxoplasma gondii SAG1/Major surface antigen p30 Antibody (SAA2154) [SAA2154] (JN902013) is a human monoclonal antibody detecting Major surface antigen p30 in ELISA. Suitable for Toxoplasma gondii.
Species reactivityToxoplasma gondii
ApplicationsELISA
Host speciesHuman
IsotypeIgG1
Clone IDSAA2154
Clonality Monoclonal
Target Major surface antigen p30
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P13664
RRID Anti-Toxoplasma gondii SAG1/Major surface antigen p30 Antibody (SAA2154) (abinScience Cat# JN902013, RRID:AB_3729523)
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information
Application Dilution
ELISA 1:2000-1:20000
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Background

Major surface antigen p30 (SAG1) is a ~34 kDa protein. Mediates binding to host cells and is especially important for parasite attachment and fitness in IFN-gamma/IFNG-stimulated host cells. May regulate binding between human S100A6 and vimentin (VIM) for cytoskeleton organization during the early stages of invasion into host cells. Promotes TNF secretion in host cells probably by enhancing binding between human VIM and PRKCQ and activating NF-kappa-B pathway. Promotes viability of host cells to satisfy the survival needs of parasites through the interaction with human RACK1.

1. Robinson, SA. et al. (2004) Parasitology 128, 391-6. PMID: 15151144
2. Cohen, O. et al. (2025) Infection and immunity 93, e0001025. PMID: 40607979
3. Zhou, LJ. et al. (2021) iScience 24, 103514. PMID: 34950858
4. Wang, D. et al. (2024) Acta tropica 251, 107112. PMID: 38157925
Note For research use only.
Images
  • Anti-Toxoplasma gondii SAG1/Major surface antigen p30 Antibody (SAA2154)

    SDS-PAGE

    SDS-PAGE for Anti-Toxoplasma gondii SAG1/Major surface antigen p30 Antibody (SAA2154)

  • Anti-Toxoplasma gondii SAG1/Major surface antigen p30 Antibody (SAA2154)

    Western blot

    Western blot analysis was performed using anti-/ monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant Toxoplasma gondii SAG1/Major surface antigen p30(Catalog No: JN902012)
    Lane 2: negative control
    Lane 3: negative control

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list